Emyria completes first approved MDMA-assisted therapy dosing

Emyria Ltd has safely dosed its first participant of its ethics-approved MDMA-assisted therapy (MDMA-AT) trial, EMDMA-001.  This is a significant milestone...

Related Keywords

United States , Australia , Australians , Jon Laugharne , Emyria Pax Centre , Multidisciplinary Association For Psychedelic Studies , Emyria Ltd , Goods Administration , Post Traumatic Stress Disorder , Authorised Prescriber , Emerald Clinics , Pax Centre , Revenue Streams , Multidisciplinary Association , Psychedelic Studies , Real World Data ,